Agilent Technologies, Inc. $A Shares Acquired by Capital Fund Management S.A.

Key Points

• Capital Fund Management S.A. increased its stake in Agilent Technologies by 45.7% during the first quarter, bringing its total ownership to 48,427 shares valued at approximately $5.67 million.
• Several other institutional investors also boosted their positions in Agilent, with a collective ownership of 87.41% of the company's stock.
• Agilent Technologies reported a quarterly EPS of $1.31, exceeding analyst expectations, and announced a *FY 2025 guidance* of $5.540-5.610 EPS.

Capital Fund Management S.A. raised its stake in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 45.7% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 48,427 shares of the medical research company's stock after purchasing an additional 15,188 shares during the period. Capital Fund Management S.A.'s holdings in Agilent Technologies were worth $5,665,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of A. Whipplewood Advisors LLC increased its position in Agilent Technologies by 286.2% during the first quarter. Whipplewood Advisors LLC now owns 251 shares of the medical research company's stock worth $29,000 after purchasing an additional 186 shares during the last quarter. Sunbelt Securities Inc. increased its position in Agilent Technologies by 640.0% during the fourth quarter. Sunbelt Securities Inc. now owns 222 shares of the medical research company's stock worth $30,000 after purchasing an additional 192 shares during the last quarter. Stone House Investment Management LLC acquired a new position in Agilent Technologies during the first quarter worth approximately $30,000. Opal Wealth Advisors LLC acquired a new position in Agilent Technologies during the first quarter worth approximately $31,000. Finally, Wood Tarver Financial Group LLC acquired a new stake in shares of Agilent Technologies in the fourth quarter worth $34,000.

Wall Street Analyst Weigh In

A has been the subject of several recent research reports. UBS Group dropped their price objective on shares of Agilent Technologies from $150.00 to $130.00 and set a "neutral" rating for the company in a research report on Thursday, May 29th. Wall Street Zen raised shares of Agilent Technologies from a "hold" rating to a "buy" rating in a report on Saturday, June 28th. Robert W. Baird lowered their price target on shares of Agilent Technologies from $159.00 to $140.00 and set an "outperform" rating for the company in a report on Thursday, May 22nd. Evercore ISI raised their price target on shares of Agilent Technologies from $125.00 to $130.00 and gave the company an "in-line" rating in a report on Tuesday, July 8th. Finally, JPMorgan Chase & Co. lowered their price target on shares of Agilent Technologies from $160.00 to $155.00 and set an "overweight" rating for the company in a report on Thursday, May 29th. Six research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $138.83.

Agilent Technologies Stock Up 0.6%

A stock traded up $0.75 during mid-day trading on Wednesday, hitting $119.05. 1,148,785 shares of the company were exchanged, compared to its average volume of 1,937,188. The company has a market capitalization of $33.82 billion, a PE ratio of 29.38, a price-to-earnings-growth ratio of 3.62 and a beta of 1.22. The company has a current ratio of 2.09, a quick ratio of 1.60 and a debt-to-equity ratio of 0.55. Agilent Technologies, Inc. has a twelve month low of $96.43 and a twelve month high of $153.84. The firm has a fifty day simple moving average of $117.93 and a 200 day simple moving average of $116.88.

Agilent Technologies (NYSE:A - Get Free Report) last announced its quarterly earnings data on Wednesday, May 28th. The medical research company reported $1.31 earnings per share for the quarter, topping the consensus estimate of $1.26 by $0.05. The company had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.63 billion. Agilent Technologies had a net margin of 17.59% and a return on equity of 25.92%. The firm's revenue for the quarter was up 6.0% compared to the same quarter last year. During the same period last year, the business earned $1.22 EPS. On average, research analysts forecast that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,508 shares of the firm's stock in a transaction on Tuesday, July 1st. The shares were sold at an average price of $117.44, for a total transaction of $177,099.52. Following the completion of the transaction, the chief executive officer directly owned 37,448 shares of the company's stock, valued at $4,397,893.12. This trade represents a 3.87% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.